首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Evaluation of prescribing pattern and rationality of fixed dose combinations in patients of general medicine department
【24h】

Evaluation of prescribing pattern and rationality of fixed dose combinations in patients of general medicine department

机译:普通医学署患者固定剂量组合规定模式的评价及合理性

获取原文
           

摘要

Background: Fixed dose combinations are widely used in India, they are either irrational or prescribed irrationally. Moreover, the government has recently banned over 300 fixed dose combinations (FDCs) because of a lack of therapeutic justification. This study was conducted to study the prescribing pattern of FDCs in a tertiary care teaching hospital and to highlight the rationality of FDCs, and adverse drug reactions (ADRs) associated with them. Methods: In the present prospective observational study, a total of 500 inpatients were evaluated for prescribing pattern, cost analysis, and adverse drug reactions (ADRs) of FDCs. The FDCs were assessed for their rationality. The ADRs and severity were assessed using the WHO causality scale, Hartwig severity scale respectively. Results: Out of total 103 FDCs, 58 were approved, 86 were rational and 17 were irrational. 5 FDCs were banned and irrational. 48.54% of rational FDCs had rationality score from 7 to 9. The most commonly prescribed FDCs belonged to the anatomic therapeutic and chemical class of respiratory system, followed by anti-infectives in younger age group and cardiovascular FDCs in the elderly. The 886 ADRs occurred in 500 patients with a mean of 1.81±1.9. Banned FDCs contributed to 76 ADRs. According to causality and severity assessment, most of the ADRs were possible (62.53%) and mild (70.77%) respectively. Conclusions: Although FDCs were rational in most cases but banned FDCs were also prescribed. As these FDCs were associated with ADRs, monitoring of patients is necessary. Knowledge and attitude of healthcare professionals can be assessed through awareness programs.
机译:背景:固定剂量组合广泛用于印度,它们是非理性的或规定的。此外,由于缺乏治疗理由,政府最近禁止过300多种固定剂量组合(FDCS)。进行了本研究以研究高等教育教学医院中FDC的规定模式,并突出与它们相关的FDCs的合理性,以及与它们相关的不良药物反应(ADRS)。方法:在目前的前瞻性观察研究中,评估了总共500种住院患者,用于处方的FDC的模式,成本分析和不良药物反应(ADRS)。对其合理性评估了FDC。使用WHO因果规模,Hartwig严重等级分别评估ADR和严重程度。结果:出于总共103个FDC,58人获得批准,86个是理性的,17个是不合理的。 5个FDC被禁止和非理性。 48.54%的理性FDCs从7到9中具有合理性评分。最常见的FDC属于呼吸系统的解剖治疗和化学类别,其次是患者患者的抗感染性和老年人的心血管FDC。 886 ADRS发生在500名均值1.81±1.9的患者中。被禁止的FDC贡献为76个ADRS。根据因果关系和严重程度评估,分别是大多数ADRs(62.53%)和轻度(70.77%)。结论:虽然FDC在大多数情况下都是理性的,但也规定了禁止的FDC。由于这些FDC与ADR相关,因此需要监测患者。通过认识计划可以评估医疗保健专业人员的知识和态度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号